We are live on ! Find out more
CRB

Chad R. Baker Portfolio holdings

AUM $620M Turnover 12.28%
1-Year Est. Return 42.67%
This Fund
S&P 500
This Quarter Est. Return
+8.97%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.08%
10 Year Est. Return
+563.15%
AUM
$445M
AUM Growth
+$27.4M
Cap. Flow
-$6.37M
Cap. Flow %
-1.43%
Top 10 Hldgs %
42.16%
Holding
54
New
1
Increased
–
Reduced
5
Closed
3
Avg Time Held
4 years
Top 10 Avg Time Held
1.9 years
Top 20 Avg Time Held
3.3 years

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$4.71M

Top Sells

Rank Stock Value
1
FISV icon
Fiserv Inc
FISV
+$3.38M
2
NSC icon
Norfolk Southern
NSC
+$2.63M
3
IFF icon
International Flavors & Fragrances
IFF
+$1.4M
4
PFE icon
Pfizer
PFE
+$933K
5
NVS icon
Novartis
NVS
+$796K

Sector Composition

Rank Sector Weight
1 Technology 23.49%
2 Healthcare 21.12%
3 Industrials 16.32%
4 Consumer Discretionary 12.03%
5 Communication Services 11.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SYY icon
26
Sysco
SYY
$40.4B
$7.62M 1.71%
98,015
– –
2020 Q2
4 quarters
CVS icon
27
CVS Health
CVS
$118B
$7.61M 1.71%
91,180
– –
2019 Q4
6 quarters
PG icon
28
Procter & Gamble
PG
$370B
$7.55M 1.7%
55,980
– –
2015 Q4
22 quarters
GOOG icon
29
Alphabet (Google) Class C
GOOG
$4.12T
$5.66M 1.27%
45,120
– –
2015 Q4
22 quarters
LOW icon
30
Lowe's Companies
LOW
$111B
$5.45M 1.23%
28,100
– –
2015 Q4
22 quarters
HD icon
31
Home Depot
HD
$309B
$5.42M 1.22%
17,000
– –
2015 Q4
22 quarters
ADBE icon
32
Adobe
ADBE
$95.4B
$5.27M 1.19%
9,000
– –
2015 Q4
22 quarters
SYK icon
33
Stryker
SYK
$113B
$4.97M 1.12%
19,145
– –
2017 Q1
17 quarters
MDT icon
34
Medtronic
MDT
$121B
$4.66M 1.05%
+37,550
New +$4.71M
2021 Q2
0 quarters
WMT icon
35
Walmart Inc
WMT
$943B
$4.65M 1.05%
99,000
– –
2015 Q4
22 quarters
ZTS icon
36
Zoetis
ZTS
$32.8B
$4.63M 1.04%
24,818
– –
2015 Q4
22 quarters
TDOC icon
37
Teladoc Health
TDOC
$1.03B
$4.24M 0.95%
25,470
– –
2018 Q2
12 quarters
CL icon
38
Colgate-Palmolive
CL
$75B
$4.17M 0.94%
51,200
– –
2015 Q4
22 quarters
RTX icon
39
RTX Corp
RTX
$261B
$3.98M 0.9%
46,696
– –
2020 Q2
4 quarters
CSX icon
40
CSX Corp
CSX
$90.2B
$3.27M 0.74%
102,000
– –
2015 Q4
22 quarters
MMM icon
41
3M
MMM
$85B
$3.18M 0.71%
19,136
– –
2015 Q4
22 quarters
FISV icon
42
Fiserv Inc
FISV
$25.3B
$2.56M 0.58%
24,000
-29,100
-55% -$3.38M
2020 Q1
5 quarters
BDX icon
43
Becton Dickinson
BDX
$52.2B
$2.43M 0.55%
10,250
– –
2020 Q1
5 quarters
MRK icon
44
Merck
MRK
$360B
$1.69M 0.38%
21,700
-10,345
-32% -$769K
2015 Q4
22 quarters
CI icon
45
Cigna
CI
$79.9B
$1.39M 0.31%
5,841
– –
2018 Q4
10 quarters
CNI icon
46
Canadian National Railway
CNI
$73.6B
$1.06M 0.24%
10,050
– –
2015 Q4
22 quarters
FTV icon
47
Fortive
FTV
$17.5B
$1.05M 0.24%
19,905
– –
2016 Q3
19 quarters
XOM icon
48
ExxonMobil
XOM
$736B
$1.03M 0.23%
16,400
-9,901
-38% -$591K
2015 Q4
22 quarters
WIRE icon
49
DELISTED
Encore Wire Corp
WIRE
$985K 0.22%
13,000
– –
2015 Q4
22 quarters
PFE icon
50
Pfizer
PFE
$169B
$959K 0.22%
24,500
-24,000
-49% -$933K
2015 Q4
22 quarters

Similar funds

Chad R. Baker's Q2 2021 Portfolio in Review

As of Q2 2021, Chad R. Baker held 54 positions worth $445M, up 6.6% from $417M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Chad R. Baker's Q2 2021 filing shows 1 new, 5 reduced and 3 closed positions. Its largest new stake was Medtronic: 37,550 shares worth $4.66M. The largest sale was Fiserv Inc, an estimated $3.38M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

  • Chad R. Baker's largest Q2 2021 buy was Medtronic: 37,550 shares worth $4.66M.
  • Chad R. Baker's biggest Q2 2021 reduction was Fiserv Inc, cutting an estimated $3.38M.
  • Chad R. Baker fully exited International Flavors & Fragrances in Q2 2021, selling an estimated $1.4M.
  • Chad R. Baker's ten largest holdings make up 42% of its $445M portfolio in Q2 2021.
  • Chad R. Baker opened 1 new position and closed 3 in Q2 2021.
  • Chad R. Baker's portfolio value rose 6.6% quarter-over-quarter to $445M.

Based on Chad R. Baker's 13F filing for Q2 2021, filed 4 Aug 2021.